37) Tumor suppressor protein p19(ARF) (Arf; p1 |
38) n of a collection of genes, including the tumor suppressor IGFBP3. |
39) Mice with heterozygous disruption of the tumor suppressor Men1 gene (Men1(+/-)) dev |
40) Thus, miR-193a-3p/5p functions as a tumor suppressor and has an important role |
41) ells, demonstrated that miR-506 acts as a tumor suppressor by inhibiting cervical ca |
42) only methylated in lung cancer, and exert tumor suppressor effects in vivo through m |
43) t Notch2 mediates differentiation and has tumor suppressor functions during lung car |
44) rum amyloid A1 (SAA1) is an NPC candidate tumor suppressor gene. |
45) Many oncogenes and tumor suppressor genes control metabolism |
46) er, these findings suggest that GAS5 is a tumor suppressor in NSCLC, and the action |
47) ata, we propose RIPK4 as a novel putative tumor suppressor in human hepatocarcinogen |
48) OIS acts as a bona fide tumor suppressor mechanism by driving stab |
49) The tumor suppressor p53 is a central regulato |
50) The tumor suppressor p53, nuclear factor-κB ( |
51) nd SAA1.3 are the dominant alleles of the tumor suppressor phenotype. |
52) ional loss of the von Hippel-Lindau (VHL) tumor suppressor protein (pVHL), which is |
53) 2 is a critical negative regulator of the tumor suppressor protein p53. |
54) yc-triggered mammary tumorigenesis, and a tumor suppressor role of E2F2 in Myc-media |
55) ing the expression of their corresponding tumor suppressor targets. |
56) protein AJUBA, a binding partner of large tumor suppressor type 2 (LATS2), which is |
57) kinase signaling, and is implicated as a tumor suppressor. |
58) r with Mdm2, negatively regulates the p53 tumor suppressor. |
59) s indicates that GAS5 might function as a tumor suppressor. |
60) s that they represent early events during tumor progression and additional alteratio |
61) atterns have been shown to correlate with tumor progression and metastasis. |
62) functional role of SAA1 polymorphisms in tumor progression and to investigate the r |
63) rant ANG levels promote specific steps in tumor progression are unknown. |
64) Local progression was defined as tumor progression by imaging, or if other |
65) titative optical biomarkers of epithelial tumor progression by use of nonlinear opti |
66) n factor CUX1 as an important mediator of tumor progression in PDAC. |
67) s triggers inflammation and thus promotes tumor progression in a cell non-autonomous |
68) thermore, its expression increased during tumor progression in a genetic mouse model |
69) n higher stage tumors and correlated with tumor progression in breast cancer patient |
|